13. Elford EL, Loncaric A, Kalista T, et al. Treatment of photodamaged skin using fractional non-ablative laser in combination with topical antioxidants. Presented at American Society for Laser Medicine and Surgery Annual Meeting; April 20-22, 2012; Kissimmee, FL.
14. Saedi N, Petrell K, Arndt K, et al. Evaluating facial pores and skin texture after low-energy nonablative fractional 1440-nm laser treatments. J Am Acad Dermatol. 2013;68:113-118.
15. Marmon S, Shek SY, Yeung CK, et al. Evaluating the safety and efficacy of the 1,440-nm laser in the treatment of photodamage in Asian skin. Lasers Surg Med. 2014;46:375-379.
16. Brauer JA, Alabdulrazzaq H, Bae YS, et al. Evaluation of a low energy, low density, non-ablative fractional 1927nm wavelength laser for facial skin resurfacing. J Drugs Dermatol. 2015;14:1262-1267.
17. Geddes ER, Stout AB, Friedman PM. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser. Lasers Surg Med. 2017;49:20-26.
18. Vanaman Wilson MJ, Jones IT, Bolton J, et al. The safety and efficacy of treatment with a 1,927-nm diode laser with and without topical hydroquinone for facial hyperpigmentation and melasma in darker skin types. Dermatol Surg. 2018;44:1304-1310.
19. Bae YC, Rettig S, Weiss E, et al. Treatment of post-inflammatory hyperpigmentation in patients with darker skin types using a low energy 1,927 nm non-ablative fractional laser: a retrospective photographic review analysis. Lasers Surg Med. 2020;52:7-12.
20. Croix J, Burge S, Chwalek J, et al. Split-sided chest study of skin rejuvenation comparing low-energy, 1,927-nm thulium fractional laser treatment prior to photodynamic therapy versus photodynamic therapy alone. Lasers Surg Med. 2020;52:53-60.
21. Leyden JJ. Clinical features of ageing skin. Br J Dermatol. 1990;122:1-3.
22. Uitto J, Fazio MJ, Olsen DR. Molecular mechanisms of cutaneous aging. Age-associated connective tissue alterations in the dermis. J Am Acad Dermatol. 1989;21:614-622.
23. Vierkötter A, Hüls A, Yamamoto A, et al. Extrinsic skin ageing in German, Chinese and Japanese women manifests differently in all three groups depending on ethnic background, age and anatomical site. J Dermatol Sci. 2016;83:219-225.
24. Bruce S. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months. J Drugs Dermatol. 2013;12:S27-S31.
25. Narins RS, Brandt F, Leyden J, et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29:588-595.
14. Saedi N, Petrell K, Arndt K, et al. Evaluating facial pores and skin texture after low-energy nonablative fractional 1440-nm laser treatments. J Am Acad Dermatol. 2013;68:113-118.
15. Marmon S, Shek SY, Yeung CK, et al. Evaluating the safety and efficacy of the 1,440-nm laser in the treatment of photodamage in Asian skin. Lasers Surg Med. 2014;46:375-379.
16. Brauer JA, Alabdulrazzaq H, Bae YS, et al. Evaluation of a low energy, low density, non-ablative fractional 1927nm wavelength laser for facial skin resurfacing. J Drugs Dermatol. 2015;14:1262-1267.
17. Geddes ER, Stout AB, Friedman PM. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser. Lasers Surg Med. 2017;49:20-26.
18. Vanaman Wilson MJ, Jones IT, Bolton J, et al. The safety and efficacy of treatment with a 1,927-nm diode laser with and without topical hydroquinone for facial hyperpigmentation and melasma in darker skin types. Dermatol Surg. 2018;44:1304-1310.
19. Bae YC, Rettig S, Weiss E, et al. Treatment of post-inflammatory hyperpigmentation in patients with darker skin types using a low energy 1,927 nm non-ablative fractional laser: a retrospective photographic review analysis. Lasers Surg Med. 2020;52:7-12.
20. Croix J, Burge S, Chwalek J, et al. Split-sided chest study of skin rejuvenation comparing low-energy, 1,927-nm thulium fractional laser treatment prior to photodynamic therapy versus photodynamic therapy alone. Lasers Surg Med. 2020;52:53-60.
21. Leyden JJ. Clinical features of ageing skin. Br J Dermatol. 1990;122:1-3.
22. Uitto J, Fazio MJ, Olsen DR. Molecular mechanisms of cutaneous aging. Age-associated connective tissue alterations in the dermis. J Am Acad Dermatol. 1989;21:614-622.
23. Vierkötter A, Hüls A, Yamamoto A, et al. Extrinsic skin ageing in German, Chinese and Japanese women manifests differently in all three groups depending on ethnic background, age and anatomical site. J Dermatol Sci. 2016;83:219-225.
24. Bruce S. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months. J Drugs Dermatol. 2013;12:S27-S31.
25. Narins RS, Brandt F, Leyden J, et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29:588-595.
AUTHOR CORRESPONDENCE
Roy G. Geronemus MD
E-mail: rgeronemus@laserskinsurgery.com
E-mail: rgeronemus@laserskinsurgery.com
